ASN
CMPI

Advisory Services Network’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

Advisory Services Network’s Portfolio CMPI Stock Details CMPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,800
Closed -$46K – 3600
2021
Q2 		$46K Buy
+7,800
New +$55.1K ﹤0.01% 2059

Other funds holding CMPI

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Advisory Services Network's CMPI Position: Q3 2021 in Review

Advisory Services Network sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q3 2021, closing a stake of 7,800 shares — an estimated $46K sold.

Advisory Services Network first reported a position in CMPI in Q2 2021 and held it in 1 quarter. The position peaked at $46K in Q2 2021. 31 funds tracked by Wall St. Rank hold CMPI as of Q3 2021.

  • Advisory Services Network reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Advisory Services Network sold 7,800 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $46K.
  • Advisory Services Network first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Advisory Services Network's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $46K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.